ConductScience.org, home

Paper · 30387828

UBA2 promotes proliferation of colorectal cancer.

He P and 8 others. Mol Med Rep, 2018. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. UBA2 promotes proliferation of colorectal cancer. Papers, record 30387828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30387828

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
UBA2 promotes proliferation of colorectal cancer.
PubMed
Journal
Mol Med Rep
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2019-04-12
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1He PPing
2Sun XXun
3Cheng HJHong-Jing
4Zou YBYa-Bin
5Wang QQuan
6Zhou CLChang-Li
7Liu WQWan-Qi
8Hao YMYue-Ming
9Meng XWXiang-Wei

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Ubiquitin-Activating EnzymesMajor topic
Adult
Aged
Animals
Cell Cycle
Cell Line, Tumor
Cell Movement
Cell Proliferation
Disease Models, Animal
Female
Gene Expression
Humans
Male
Mice
Middle Aged
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Prognosis

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,920,803In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.Biochem Biophys Res Commun1999https://conductscience.org/library/papers/9920803PubMed
218,473,732The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.Curr Cancer Drug Targets2008https://conductscience.org/library/papers/18473732PubMed
328,284,030SUMO conjugation - a mechanistic view.Biomol Concepts2017https://conductscience.org/library/papers/28284030PubMed
421,037,263starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.Nucleic Acids Res2011https://conductscience.org/library/papers/21037263PubMed
523,673,635SUMO2/3 modification of cyclin E contributes to the control of replication origin firing.Nat Commun2013https://conductscience.org/library/papers/23673635PubMed
624,297,251starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.Nucleic Acids Res2014https://conductscience.org/library/papers/24297251PubMed
725,869,096Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation.J Proteome Res2015https://conductscience.org/library/papers/25869096PubMed
827,916,539Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.Stem Cell Reports2016https://conductscience.org/library/papers/27916539PubMed
927,456,362Depletion of UBA protein 2-like protein inhibits growth and induces apoptosis of human colorectal carcinoma cells.Tumour Biol2016https://conductscience.org/library/papers/27456362PubMed
1025,860,128Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.PLoS One2015https://conductscience.org/library/papers/25860128PubMed

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42,373,928UBA2: the gatekeeper of the sumoylation pathway and its multifaceted roles in human diseases and therapeutic prospects.Clin Exp Med2026https://conductscience.org/library/papers/42373928PubMed
40,918,458MYH11 Suppresses Colorectal Cancer Progression by Inhibiting Epithelial-Mesenchymal Transition via ZEB1 Regulation.Oncol Res2025https://conductscience.org/library/papers/40918458PubMed
40,741,192Molecular mechanisms of thymopoietin in papillary thyroid cancer: Multiplatform gene expression data, gene knockout screening, and in-house immunohistochemistry.World J Clin Oncol2025https://conductscience.org/library/papers/40741192PubMed
37,777,749Role of non-canonical post-translational modifications in gastrointestinal tumors.Cancer Cell Int2023https://conductscience.org/library/papers/37777749PubMed
37,056,932IGF2BP3 Regulates TMA7-mediated Autophagy and Cisplatin Resistance in Laryngeal Cancer via m6A RNA Methylation.Int J Biol Sci2023https://conductscience.org/library/papers/37056932PubMed
36,388,702Nestin protein affects the maintenance of stem characteristics of colorectal cancer cells based on p53 dependent pathway.J Gastrointest Oncol2022https://conductscience.org/library/papers/36388702PubMed
35,992,817Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy.Front Oncol2022https://conductscience.org/library/papers/35992817PubMed
35,859,792Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferation.Open Med (Wars)2022https://conductscience.org/library/papers/35859792PubMed
35,661,832circXRCC5 foster gastric cancer growth and metastasis by the HNRNPC/circXRCC5/miR-655-3p/RREB1/UBA2 positive feedback loop.Cancer Gene Ther2022https://conductscience.org/library/papers/35661832PubMed
34,930,905WTIP upregulates FOXO3a and induces apoptosis through PUMA in acute myeloid leukemia.Cell Death Dis2021https://conductscience.org/library/papers/34930905PubMed

1 to 10 of 17

See all 17 cited by

Genes24

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30387828

GET https://conductscience.org/api/papers/v1/30387828/references?page=2